Visit us at ESTRO in Vienna
2023-05-04 16:00
May 12-15, onsite in Vienna at booth #1000.
Spectronic Medical is the leading provider of synthetic CT technology for MRI only RT planning for any MRI scanner and treatment planning system. Our team of experts will be onsite at ESTRO to present and demonstrate the latest advances in MRI only RT planning technology.
If you are interested in implementing an MRI only workflow at your clinic or if you just want to learn more about our technology, you are very welcome to visit our booth at location #1000. We are present during all conference hours. If you wish to book a meeting with us at a specific time during the conference, please send us an email at sales@spectronic.se
We look forward to meeting with you in Vienna.
Visit us at the MRinRT meeting
2022-12-22 17:42
6-8 February onsite at campus UCLA, Luskin Conference Center, Los Angeles
Spectronic Medical is the leading provider of synthetic CT technology for MRI only RT planning for any MRI scanner and treatment planning system. Our technology is now also available for clinical use in the United States. Our team of experts will be onsite at the MRinRT meeting to present and demonstrate the latest advances in MRI only RT planning technology.
If you are interested in implementing an MRI only workflow at your clinic or if you just want to learn more about our technology, you are very welcome to meet with us at the MRinRT meeting in Los Angeles. We are present during all conference hours. If you wish to book a meeting with us, please send us an email at sales@spectronic.se
We look forward to seeing you in Los Angeles.
Spectronic Medical is recruiting for three new exciting positions
2022-12-15 12:10
Spectronic Medical is now recruiting staff for three new exciting positions in software development, clinical science and installation engineering. If you are interested in working with us, please find more information about these positions on our career page.
Meet with us at ASTRO
2022-09-29 15:19
Spectronic Medical will be present at the annual ASTRO meeting in San Antonio, Texas, 23-25 October 2022. Don't hesitate to let us know if you would like to meet to discuss how we can help you with your MRI only RT implementation.
Please reach out to us through our contact form
Visit us at ESTRO
2022-04-27 13:29
6-9 May onsite in Copenhagen at booth #890.
Spectronic Medical is the leading provider of synthetic CT technology for MRI only RT planning for any MRI scanner and treatment planning system. Our team of experts will be onsite at ESTRO to present and demonstrate the latest advances in MRI only RT planning technology.
If you are interested in implementing an MRI only workflow at your clinic or if you just want to learn more about our technology, you are very welcome to visit our booth at location #890. We are present during all conference hours. If you wish to book a meeting with us at a specific time during the conference, please send us an email at sales@spectronic.se
We look forward to seeing you in Copenhagen.
Joint our MR in RT webinar with GE Healthcare on April 5th at 4pm CET
2022-03-24 12:03
Please register and find more details below:
https://landing1.gehealthcare.com/RTMRSPECT_Registrationpage.html
Canon Medical and Spectronic Medical to offer integrated AI solution for accurate radiotherapy planning with MRI
2021-12-03 10:37
Otawara, Tochigi Prefecture, Japan, 3 December 2021
Canon Medical has announced integration with Spectronic Medical’s MRI Planner software to strengthen its presence in the field of radiotherapy planning. Utilizing an innovative AI application, the MRI Planner software provided by Spectronic Medical is a technology that utilizes standard MR images to create synthetic CT images, including depictions of organs at risk. Combined with outstanding noise-free images produced by Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE), powered by Altivity, MR labs utilizing this solution can aim for accurate oncology treatment planning services. With the benefit of MRI’s fine delineation of contrast between soft tissues allowing target lesions to be clearly depicted in synthetic CT images, radiotherapy planning can be completely conducted in the MRI lab. In addition, with Canon Medical’s suite of accelerated scan technologies, including 2D and 3D Compressed SPEEDER, MR labs can look forward to the reduced procedural time.
Radiation therapy, along with surgery and chemotherapy, is one of the three pillars of cancer treatment. Spectronic Medical MRI Planner software is currently CE marked and approved for use in pelvic, brain, head and neck radiotherapy planning in Europe, and it is FDA 510(k) pending in the US.
As part of Canon Medical’s commitment to improving workflow in the MRI lab, including oncology services, Canon Medical is leading the way in utilizing AI to improve imaging solutions across the procedural pathway. The integration with Spectronic Medical’s technique marks another step in Canon Medical’s evolution to improve diagnostic accuracy and save the valuable time of physicians, staff and patients.
https://global.medical.canon/News/PressRelease/Detail/110407-834
Canon Medical has announced integration with Spectronic Medical’s MRI Planner software to strengthen its presence in the field of radiotherapy planning. Utilizing an innovative AI application, the MRI Planner software provided by Spectronic Medical is a technology that utilizes standard MR images to create synthetic CT images, including depictions of organs at risk. Combined with outstanding noise-free images produced by Canon Medical’s Advanced intelligent Clear-IQ Engine (AiCE), powered by Altivity, MR labs utilizing this solution can aim for accurate oncology treatment planning services. With the benefit of MRI’s fine delineation of contrast between soft tissues allowing target lesions to be clearly depicted in synthetic CT images, radiotherapy planning can be completely conducted in the MRI lab. In addition, with Canon Medical’s suite of accelerated scan technologies, including 2D and 3D Compressed SPEEDER, MR labs can look forward to the reduced procedural time.
Radiation therapy, along with surgery and chemotherapy, is one of the three pillars of cancer treatment. Spectronic Medical MRI Planner software is currently CE marked and approved for use in pelvic, brain, head and neck radiotherapy planning in Europe, and it is FDA 510(k) pending in the US.
As part of Canon Medical’s commitment to improving workflow in the MRI lab, including oncology services, Canon Medical is leading the way in utilizing AI to improve imaging solutions across the procedural pathway. The integration with Spectronic Medical’s technique marks another step in Canon Medical’s evolution to improve diagnostic accuracy and save the valuable time of physicians, staff and patients.
https://global.medical.canon/News/PressRelease/Detail/110407-834
GE Healthcare will showcase Spectronic Medical's AI-based software at ASTRO 2021
2021-10-22 15:32
Chicago, October 22, 2021
At this year’s ASTRO 2021 event in Chicago, GE Healthcare will showcase Spectronic Medical AB’s AI-based software for more precise cancer treatment planning.
GE Healthcare will integrate Spectronic Medical's AI-based software for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s advanced AIR Recon DL technology, offers a deep learning solution and radiation therapy treatment planning alternative to standard CT images. The combined solution begins with GE Healthcare’s AIR Recon DL, a deep learning image reconstruction technology that leverages raw data from the MR scanner to reduce image noise, maximize image quality and resolution, and shorten scan times. The high-quality MR images generated by the GE scanner are then converted into synthetic CT images by Spectronic Medical’s AI-based solution, providing clinicians with the CT images they have come to expect with MR soft tissue details to more accurately target lesions and help improve patient outcomes.
https://www.ge.com/news/press-releases/ge-healthcare-advances-precision-radiation-therapy-solutions-with-new-products
At this year’s ASTRO 2021 event in Chicago, GE Healthcare will showcase Spectronic Medical AB’s AI-based software for more precise cancer treatment planning.
GE Healthcare will integrate Spectronic Medical's AI-based software for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s advanced AIR Recon DL technology, offers a deep learning solution and radiation therapy treatment planning alternative to standard CT images. The combined solution begins with GE Healthcare’s AIR Recon DL, a deep learning image reconstruction technology that leverages raw data from the MR scanner to reduce image noise, maximize image quality and resolution, and shorten scan times. The high-quality MR images generated by the GE scanner are then converted into synthetic CT images by Spectronic Medical’s AI-based solution, providing clinicians with the CT images they have come to expect with MR soft tissue details to more accurately target lesions and help improve patient outcomes.
https://www.ge.com/news/press-releases/ge-healthcare-advances-precision-radiation-therapy-solutions-with-new-products
GE Healthcare announces the integration of Spectronic Medical AI-based software
2021-07-09 16:30
Chicago/Helsingborg, Sweden July 9, 2021:
GE Healthcare announces the integration of Spectronic Medical AB AI-based software for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.
GE Healthcare and Spectronic Medical are combining technologies to offer a complete deep learning solution. The process begins with GE Healthcare’s AIR Recon DL, a deep learning image reconstruction technology that makes full use of all the raw data coming off the MR scanner to reduce image noise, maximize image quality and resolution, and shorten scan times. The high-quality MR images generated by the GE scanner are then converted into synthetic CT images by Spectronic Medical’s AI-based solution, providing clinicians with the CT images they have come to expect with the MR soft tissue details they need to more accurately target lesions and help improve patient outcomes.
“By using an MR image and creating a synthetic CT image, our MRI Planner software is designed to improve accuracy, increasing the precision by which radiotherapy can be delivered to the patient, as well as simplifying the physician’s workflow,” said Spectronic Medical CEO Carl Siversson. “Our customers say the benefits are enormous – it could increase the chances of successful cancer treatment and minimize the negative side-effects from radiotherapy, which often follow patients throughout their lives.”
“Already, AIR Recon DL has benefited over a half a million patients around the world, with clinical users observing sharper and less noisy images and up to a 50% reduction in exam times[3],” said Ben Newton, general manager, Oncology, at GE Healthcare. “Now, we are delighted to combine this breakthrough image reconstruction technology with Spectronic’s AI-based software for use in brain, pelvic, head and neck radiotherapy planning[4]. Together, we are introducing a full AI and Deep Learning based MR radiation oncology solution to healthcare providers to help enable high-precision treatment planning and improve clinical outcomes for thousands of radiotherapy patients.”
https://www.ge.com/news/press-releases/ge-healthcare-to-offer-end-to-end-deep-learning-solutions-with-spectronic-medical-to
GE Healthcare announces the integration of Spectronic Medical AB AI-based software for more precise cancer treatment planning. This AI solution, in combination with GE Healthcare’s industry leading AIR Recon DL technology, enables MR-only based radiotherapy planning for better soft tissue differentiation than traditional CT, so clinicians can better direct radiotherapy.
GE Healthcare and Spectronic Medical are combining technologies to offer a complete deep learning solution. The process begins with GE Healthcare’s AIR Recon DL, a deep learning image reconstruction technology that makes full use of all the raw data coming off the MR scanner to reduce image noise, maximize image quality and resolution, and shorten scan times. The high-quality MR images generated by the GE scanner are then converted into synthetic CT images by Spectronic Medical’s AI-based solution, providing clinicians with the CT images they have come to expect with the MR soft tissue details they need to more accurately target lesions and help improve patient outcomes.
“By using an MR image and creating a synthetic CT image, our MRI Planner software is designed to improve accuracy, increasing the precision by which radiotherapy can be delivered to the patient, as well as simplifying the physician’s workflow,” said Spectronic Medical CEO Carl Siversson. “Our customers say the benefits are enormous – it could increase the chances of successful cancer treatment and minimize the negative side-effects from radiotherapy, which often follow patients throughout their lives.”
“Already, AIR Recon DL has benefited over a half a million patients around the world, with clinical users observing sharper and less noisy images and up to a 50% reduction in exam times[3],” said Ben Newton, general manager, Oncology, at GE Healthcare. “Now, we are delighted to combine this breakthrough image reconstruction technology with Spectronic’s AI-based software for use in brain, pelvic, head and neck radiotherapy planning[4]. Together, we are introducing a full AI and Deep Learning based MR radiation oncology solution to healthcare providers to help enable high-precision treatment planning and improve clinical outcomes for thousands of radiotherapy patients.”
https://www.ge.com/news/press-releases/ge-healthcare-to-offer-end-to-end-deep-learning-solutions-with-spectronic-medical-to
Spectronic Medical has signed a distribution agreement with Fimecorp International in Spain
2021-05-24 10:12
Helsingborg Monday, May 24th 2021 - Spectronic Medical has signed a distribution agreement with Fimecorp International in Spain. Under the terms of this agreement, Fimecorp International will provide marketing and sales of MRIPlanner and GRADE.
"The demand for vendor independent products to generate sCT images is growing in Europe and together with Fimecorp International, we are glad to offer our solutions MRI Planner and GRADE for Spanish customers. " says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
"The demand for vendor independent products to generate sCT images is growing in Europe and together with Fimecorp International, we are glad to offer our solutions MRI Planner and GRADE for Spanish customers. " says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
Spectronic Medical has received Thai FDA for MRI Planner
2021-04-07 12:38
Helsingborg Wednesday, April 7th 2021 - Spectronic Medical has received Thai FDA for MRI Planner.
We are glad to announce that MRI Planner is now available for Thai Hospitals who has the intentions to start with MRI only workflow. Already during the last weeks we have received two orders of MRI Planner and together with our distributor PBI in the region, we are looking forward to market our products in Thailand.
We are glad to announce that MRI Planner is now available for Thai Hospitals who has the intentions to start with MRI only workflow. Already during the last weeks we have received two orders of MRI Planner and together with our distributor PBI in the region, we are looking forward to market our products in Thailand.
Spectronic Medical has signed a distribution agreement with PBI in Thailand
2021-03-11 12:27
Helsingborg Thursday, March 11th 2021 - Spectronic Medical has signed a distribution agreement with Premier Business Inter (PBI) in Thailand. Under the terms of this agreement, PBI will provide marketing and sales of MRIPlanner and GRADE.
"We are glad to start this collaboration with PBI since the demand and need for vendor independent sCT generation for radiotherapy planning is growing in Thailand. During the last weeks, we have already received two orders for MRI Planner to hospitals in the region together with PBI." says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About PBI
Founded in 2001, Premier Business Inter Co, Ltd is a company specializing in the supply and distribution of medical equipments for therapeutic radiology ranging from a Linear Accelerator (LINAC) and Treatment Planning Machine for Cancer Patients to X-ray Simulator.
"We are glad to start this collaboration with PBI since the demand and need for vendor independent sCT generation for radiotherapy planning is growing in Thailand. During the last weeks, we have already received two orders for MRI Planner to hospitals in the region together with PBI." says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About PBI
Founded in 2001, Premier Business Inter Co, Ltd is a company specializing in the supply and distribution of medical equipments for therapeutic radiology ranging from a Linear Accelerator (LINAC) and Treatment Planning Machine for Cancer Patients to X-ray Simulator.
Spectronic Medical has signed a distribution agreement with Tema Sinergie in Italy
2020-06-08 13:41
Helsingborg Monday, June 8th 2020 - Spectronic Medical has signed a distribution agreement with Tema Sinergie in Italy. Under the terms of this agreement, Tema Sinergie will provide marketing and sales of MRIPlanner and GRADE.
"MRI only radiation therapy planning workflow is not only beneficial from a clinical perspective of view, it's also time and cost-effective. We are therefore looking forward to continue our collaboration in the Italian market and provide MRI Planner and GRADE through a dedicated and skilled team within field of Radiation therapy of Tema Sinergie." says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About Tema Sinergie
Tema Sinergie represents in Italy a fundamental reference point for modern Radiotherapy, being able to offer a wide range of highly innovative and performing products, carefully and specifically selected from the international market. Solid partnerships with main international leading companies are prestigious references of which Tema Sinergie is profoundly proud.
"MRI only radiation therapy planning workflow is not only beneficial from a clinical perspective of view, it's also time and cost-effective. We are therefore looking forward to continue our collaboration in the Italian market and provide MRI Planner and GRADE through a dedicated and skilled team within field of Radiation therapy of Tema Sinergie." says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About Tema Sinergie
Tema Sinergie represents in Italy a fundamental reference point for modern Radiotherapy, being able to offer a wide range of highly innovative and performing products, carefully and specifically selected from the international market. Solid partnerships with main international leading companies are prestigious references of which Tema Sinergie is profoundly proud.
Spectronic Medical has signed a distribution agreement with RT-Idea EU in Netherlands
2020-05-11 12:02
Helsingborg Monday, May 11th 2020 - Spectronic Medical has signed a distribution agreement with RT-Idea EU in Netherlands. Under the terms of this agreement, RT-Idea EU will provide marketing and sales of MRIPlanner and GRADE.
”We have had a good relationship with RT-Idea in the past and it is exciting to take this one step further and sign a contract for distribution in the Netherlands. MRI only workflow in radiation therapy is in an expansive phase and the demand for software that can enable this method is increasing especially in Europe. We look forward to continued good cooperation with RT-Idea EU and deliver MRI only to Hospitals in the Netherlands," says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About RT-Idea EU
RT-Idea EU B.V. is a Healthcare Technology company and premium supplier of Radiation Oncology equipment. With over 30 years of experience in the Radiation Oncology business, RT-Idea EU is a leader in providing medical workflow solutions to increase patient care.
”We have had a good relationship with RT-Idea in the past and it is exciting to take this one step further and sign a contract for distribution in the Netherlands. MRI only workflow in radiation therapy is in an expansive phase and the demand for software that can enable this method is increasing especially in Europe. We look forward to continued good cooperation with RT-Idea EU and deliver MRI only to Hospitals in the Netherlands," says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About RT-Idea EU
RT-Idea EU B.V. is a Healthcare Technology company and premium supplier of Radiation Oncology equipment. With over 30 years of experience in the Radiation Oncology business, RT-Idea EU is a leader in providing medical workflow solutions to increase patient care.
Spectronic Medical has signed a distribution agreement with Gamma Gurus in Australia and New Zealand
2020-05-06 14:12
Helsingborg Wednesday May 6th 2020 - Spectronic Medical has signed a distribution agreement with Gamma Gurus in Australia and New Zealand. Under the terms of this agreement, Gamma Gurus will provide marketing and sales of MRIPlanner and GRADE.
The interest for MRI only workflow is growing globally and there is a demand for vendor independent and reliable software to handle any kind of MRI scanner and model used for radiation therapy planning purposes. MRIPlanner gives departments the possibility to start using the groundbreaking Deep Learning technology to streamline their treatment planning workflow.
”We are excited about this collaboration and to offer our solutions through Gamma Gurus, an experienced and professional company within the field of Radiation Oncology. After initial product registration process, We are looking forward to provide MRI only workflow to Hospitals in Australia and New Zealand,” says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About Gamma Gurus
Gamma Gurus brings over 50 years of experience in diagnostic imaging, radiation therapy and radioactive material management together in one place. Our goal is to provide unsurpassed solutions and service to our customers with a professional and hassle-free attitude. Our extensive network ensures that we will be able to source the best products from around the world to meet the needs of the local healthcare community. Our decades of local knowledge guarantee that suppliers and customers alike have the support to navigate the complex regulatory, logistics and technical nuances of the local markets.
The interest for MRI only workflow is growing globally and there is a demand for vendor independent and reliable software to handle any kind of MRI scanner and model used for radiation therapy planning purposes. MRIPlanner gives departments the possibility to start using the groundbreaking Deep Learning technology to streamline their treatment planning workflow.
”We are excited about this collaboration and to offer our solutions through Gamma Gurus, an experienced and professional company within the field of Radiation Oncology. After initial product registration process, We are looking forward to provide MRI only workflow to Hospitals in Australia and New Zealand,” says Tarik Cengiz, Head of Sales & Marketing at Spectronic Medical.
About Spectronic Medical
Spectronic Medical offers unique technology for MRI only radiotherapy planning. The technology increases the precision by which radiotherapy can be delivered to the patient. Thus, the chances of successful cancer treatment are increased and the vast negative side-effects, which often follow patients throughout their lives, are minimized. Spectronic Medical technology constitutes a complete and CE marked solution for MRI only radiotherapy planning. The technology integrates seamlessly with any clinical radiotherapy workflow and treatment planning system. Through our GRADE phantom technology we also provide the QA tools required to assure the accuracy of your MRI is sufficient for radiotherapy treatment planning.
About Gamma Gurus
Gamma Gurus brings over 50 years of experience in diagnostic imaging, radiation therapy and radioactive material management together in one place. Our goal is to provide unsurpassed solutions and service to our customers with a professional and hassle-free attitude. Our extensive network ensures that we will be able to source the best products from around the world to meet the needs of the local healthcare community. Our decades of local knowledge guarantee that suppliers and customers alike have the support to navigate the complex regulatory, logistics and technical nuances of the local markets.
Spectronic Medical uses machine learning derived model to provide COVID-19 fatality prognosis
2020-04-20 15:45
Spectronic Medical now provides a dedicated web site for technical analysis and prognosis concerning the ongoing COVID-19 outbreak.
www.spectronic.se/covid-19/
Spectronic Medical supports the decision to postpone ESTRO 2020
2020-03-15 10:43
European Society for Radiation Therapy and Oncology (ESTRO) has announced that ESTRO 2020 congress which was to take place in Vienna 3-7 April is rescheduled to 31 July - 4 August due to Covid-19 outbreak. Spectronic Medical supports this careful decision stated by ESTRO and plans for attendance at the congress in July.
We look forward to meeting you in Vienna!
First German clinical MRI Planner results to be presented at the DMGP-Nord meeting
2019-11-11 09:06
An evaluation of the first 60 patients treated using MRI Planner at the Radiologische Allianz clinic in Hamburg will be presented at the Deutschen Gesellschaft für Medizinische Physik (DGMP) Nord meeting on November 15 in Hamburg.
The outcome of the evaluation is reported to be excellent. This post will be updated with a link to the presentation as soon as it is available.
The outcome of the evaluation is reported to be excellent. This post will be updated with a link to the presentation as soon as it is available.
Spectronic Medical announces the immediate release of MRI Planner version 2
2019-08-21 10:57
MRI Planner v2 introduces the deep-learning driven transfer function estimation (TFE) algorithm for ultra-robust synthetic CT (sCT) generation. The TFE algorithm generates outstanding synthetic CT images with unsurpassed level of detail using any MRI scanner. In addition, it also provides fully automated organ delineations. The currently released version is CE marked for prostate radiotherapy, but additional anatomies will follow shortly.
Processing time to generate a synthetic CT is less than five minutes and the software can easily be integrated in the clinical workflow through a secure cloud connection. MRI Planner v2 eliminates registration related uncertainties, reduces treatment costs and increases patient comfort.
A white paper describing the details of the TFE algorithm will be presented shortly.
MRI Planner v2 is available for clinical use today. Please contact our sales department if you would like to purchase or evaluate the software.
Processing time to generate a synthetic CT is less than five minutes and the software can easily be integrated in the clinical workflow through a secure cloud connection. MRI Planner v2 eliminates registration related uncertainties, reduces treatment costs and increases patient comfort.
A white paper describing the details of the TFE algorithm will be presented shortly.
MRI Planner v2 is available for clinical use today. Please contact our sales department if you would like to purchase or evaluate the software.
Visit us at booth #3430 on ESTRO 38
2019-04-10 15:42
ESTRO is the largest European radiotherapy congress and Spectronic Medical is very happy to announce its presence on this very important event. We warmly welcome everyone who has an interest in the latest development in MRI only radiotherapy planning to come and visit us in our booth at location #3430 in the main exhibition hall.
If you are interested in setting up a meeting with us during the conference please don't hesitate to contact us at sales@spectronic.se
ESTRO 38 will take place at the Milano Convention (MiCo) centre in Milan, Italy on April 26-30.
If you are interested in setting up a meeting with us during the conference please don't hesitate to contact us at sales@spectronic.se
ESTRO 38 will take place at the Milano Convention (MiCo) centre in Milan, Italy on April 26-30.
First UK prostate cancer patients treated using pioneering MRI-only radiotherapy planning technology provided by Spectronic Medical.
2019-03-06 17:34
Text cited from Newcastle Hospitals (1):
Newcastle Hospitals is revolutionising prostate cancer treatment
Prostate cancer is the commonest cancer among men in the UK. Radiotherapy is an often used treatment given to prostate cancer patients and involves delivering a very high dose of radiation to the prostate gland and as low a dose as possible to surrounding healthy organs, such as the bowel and bladder. The treatment normally requires patients to attend for a CT scan in the radiotherapy department as well as an MRI scan to gain a better image of the target and organs at risk - in this case the prostate, bowel and bladder respectively. NCCC was one of the first UK radiotherapy centres to use MRI in this way specifically for radiotherapy treatment planning.
Conventional workflow has been to combine the MRI scan with the CT data needed for accurate radiotherapy dose calculations.
Dual imaging requires patients to attend for two separate sessions. However, new MRI-only planning technology is now available which means the CT scan can be omitted. Careful validation of this approach now means that the patients need only attend for a single scanning session.
Head of Radiotherapy Physics, Chris Walker, said: “It is particularly gratifying that the implementation of the most up to date technology allows our patients to benefit from spending less time in hospital.”
Consultant Clinical Oncologist, Rachel Pearson, added: “This new MRI-only system is already being used in several European radiotherapy departments and now, here in Newcastle, we have treated the first patients in the UK using this treatment pathway.
“Using one image rather than two allows us to better target the tumour and avoid healthy organs. It also reduces the amount of time patients are in hospital and the severity of side-effects, both in the short and longer term. We are very excited that, with support from the charity Charlie Bear for Cancer Care, we are able to bring this state-of-the-art treatment to our patients in the North East.”
Keith Kirby, aged 69, from Gosforth, is one of the first patients to benefit from the new technology at NCCC. He said: “Anything that can improve the technique and make the delivery of the radiotherapy more accurate has to be a good thing. I’m only too pleased to help by being a part of this new pre-treatment.”
(1) www.newcastle-hospitals.org.uk/news/news-item-23612.aspx
(2) https://www.chroniclelive.co.uk/news/north-east-news/new-approach-prostate-cancer-therapy-15755780
(3) https://theworldnews.net/gb-news/new-approach-to-prostate-cancer-therapy-is-making-treatment-easier-for-patients-in-newcastle
(4) http://www.newslocker.com/en-uk/region/gateshead/new-approach-to-prostate-cancer-therapy-is-making-treatment-easier-for-patients-in-newcastle/view/
MRI Planner featured in two additional scientific publications
2018-11-07 16:06
Spectronic Medical is proud to announce that our MRI Planner technology has been further utilized in two additional scientific clinical research projects. We congratulate our collaboration partners at Skåne University Hospital and Sahlgrenska University Hospital for their recent publications in renowned scientific journals.
https://www.ncbi.nlm.nih.gov/pubmed/30354010
https://www.ncbi.nlm.nih.gov/pubmed/30182461
Spectronic seminar at the IPEM 2018 meeting in York
2018-09-18 08:10
In an invited seminar at the IPEM (Institute of Physics and Engineering in Medicine) annual meeting, Spectronic Medical CEO Dr. Carl Siversson
will hold a joint presentation together with Dr. Hazel McCallum from NCCC (Northern Center for Cancer Care) in Newcastle. In the presentation
the ongoing joint work between Spectronic Medical and NCCC on implementing MRI only radiotherapy planning in clinical practice in the
UK using Spectronic MRI Planner will be detailed.
The seminar will be held on September 18 at the IPEM annual meeting at the York Racecourse in York, UK.
https://www.ipem.ac.uk/ConferencesEvents/MPEC/InvitedSpeakers.aspx
Awarded as one of Sweden's hottest technology companies for the second time
2018-05-16 16:08
For the second time, Spectronic Medical has been awarded as one of Sweden's 33 hottest technology companies. The award was given by technology newspaper NyTeknik and business newspaper Affärsvärlden on an event at A-house in Stockholm on 16 May 2018. "We are very proud to receive this award again, and it proves how important the work that we do is", says Carl Siversson, CEO of Spectronic Medical. Spectronic Medical has developed an AI platform that enables multiple AI based applications for radiotherapy, including the ability to use MRI as the primary imaging modality for radiotherapy treatment planning.
https://www.nyteknik.se/startup/33-listan/spectronic-medical-ratt-straldos-med-hjalp-av-ai-6914065
https://www.affarsvarlden.se/bors-ekonominyheter/har-ar-vinnarna-av-33-listan-2018-6914680
Spectronic Medical will be present at ESTRO
2018-03-15 15:13
ESTRO is the largest european radiotherapy congress and Spectronic Medical is very happy to announce its presence on this very important event. We warmly welcome everyone who has an interest in the latest development in MRI only radiotherapy planning to come and visit us in our booth at location 6300 in the main exhibition hall.
If you are interested in setting up a meeting with us during the conference please don't hesitate to contact us at sales@spectronic.se
ESTRO will take place at the CCIB convention centre in Barcelona, Spain on April 20-23.
https://www.estro.org/congresses-meetings/items/estro-37
First 30 patients successfully treated using MRI Planner
2018-01-28 09:31
Spectronic Medical is happy to announce that the on-going clinical implementation of MRI Planner for prostate radiotherapy at Skåne University Hospital is progressing as planned. Treatment has now been successfully delivered to a first set of 30 patients, with another 30 patients planned during the spring of 2018.
The MR-OPERA multi-center study is now published in the Red Journal
2017-10-30 11:23
The MRI Only Prostate External Radiotherapy (MR-OPERA) study is now published in the November issue of the prestigious International Journal of Radiation Oncology (a.k.a. the Red Journal). The MR-OPERA study comprises a joint effort by four Swedish university hospitals, involving 170 patients, aiming at validating the use of Spectronic Medical's MriPlanner technology for prostate cancer radiotherapy.
"The MR-OPERA study is the world's largest study evaluating an MRI only workflow for radiotherapy planning. The fantastic efforts made by the participating hospitals to make this study possible shows how important our technology is to the future of radiotherapy", says Carl Siversson, CEO of Spectronic Medical.
The uniform conclusion of the study is that MRI only radiotherapy planning using MriPlanner is both accurate and robust, and also works well with a large variety of MRI scanners and clinical environments.
"The extraordinary results shows not only that our technology works very well, but also that it is now ready for large-scale deployment", says Carl Siversson and continues, "The advantages of an MRI only workflow are enormous. Not only are costs reduced and patient comfort increased, but it also opens up for personalized treatment strategies with significant therapeutic benefits"
MriPlanner is currently CE marked and ready for prostate radiotherapy planning in Europe and other regions acknowledging the CE mark. FDA approval for the US market will follow soon.
The complete MR-OPERA study can be read here:
http://www.redjournal.org/article/S0360-3016(17)31055-6/pdf
"The MR-OPERA study is the world's largest study evaluating an MRI only workflow for radiotherapy planning. The fantastic efforts made by the participating hospitals to make this study possible shows how important our technology is to the future of radiotherapy", says Carl Siversson, CEO of Spectronic Medical.
The uniform conclusion of the study is that MRI only radiotherapy planning using MriPlanner is both accurate and robust, and also works well with a large variety of MRI scanners and clinical environments.
"The extraordinary results shows not only that our technology works very well, but also that it is now ready for large-scale deployment", says Carl Siversson and continues, "The advantages of an MRI only workflow are enormous. Not only are costs reduced and patient comfort increased, but it also opens up for personalized treatment strategies with significant therapeutic benefits"
MriPlanner is currently CE marked and ready for prostate radiotherapy planning in Europe and other regions acknowledging the CE mark. FDA approval for the US market will follow soon.
The complete MR-OPERA study can be read here:
http://www.redjournal.org/article/S0360-3016(17)31055-6/pdf
Major milestone: First set of prostate cancer patients treated using Spectronic Medical's MriPlanner technology
2017-05-19 14:29
A major milestone is now reached in Spectronic Medical's development history. During the past weeks, the first set of prostate cancer patients were successfully treated at Skåne University Hospital using Spectronic Medical's MriPlanner technology. In total 60 patients are included for therapy at Skåne University Hospital using MriPlanner during 2016.
"This is not only a milestone for us but also for the national medical achievements in this field, as these treatments are the first of their kind ever to be performed in Sweden. Our MRI only radiotherapy planning technology not only reduces treatment complexity but also opens up for very exciting personalized and adaptive treatment planning strategies." says Carl Siversson, CEO of Spectronic Medical.
"This is not only a milestone for us but also for the national medical achievements in this field, as these treatments are the first of their kind ever to be performed in Sweden. Our MRI only radiotherapy planning technology not only reduces treatment complexity but also opens up for very exciting personalized and adaptive treatment planning strategies." says Carl Siversson, CEO of Spectronic Medical.
The MR-OPERA study is presented at the ESTRO conference in Vienna
2017-04-27 16:02
The MR Only Prostate External Radiotherapy (MR-OPERA) multi center validation study is presented at the ESTRO scientific conference in Vienna May 5-9. The national MR-OPERA study was performed as a collaboration between Skåne University Hospital, Norrland University hospital, Sahlgrenska University Hospital and Karolinska University hospital aiming to verify and validate Spectronic Medical's MriPlanner technology with a large cohort of 170 prostate cancer patients.
"The results presented at ESTRO are very exciting and confidently shows that our technology is robust and ready for large-scale clinical implementation", says Carl Siversson, CEO of Spectronic Medical.
The study will be presented by first author Emilia Persson from Lund University on Saturday May 6. Spectronic CEO Carl Siversson will also attend ESTRO. Please contact us if you wish to arrange a meeting at ESTRO.
Spectronic Medical is awarded as one of Sweden's 33 hottest young technology companies
2017-04-05 10:09
At an event hosted by NyTeknik and Affärsvärlden at Münchenbryggeriet in Stockholm, Spectronic Medical was awarded as one of Sweden's 33 hottest young technology companies.
"We are very happy for this recognition", says Carl Siversson, CEO of Spectronic Medical, "This award verifies our understanding that the market is now asking for the type of advanced AI driven med-tech technology we are providing".
Apart from receiving the award, Spectronic Medical also participated the event with a booth displaying its technology to a wider audience.
The awards were further recognized by Nasdaq at Times Square in New York.
Read more here:
http://www.nyteknik.se/startup/33-listan/33-nya-vinnare-tar-plats-pa-historiska-listan-6838439
https://sv-se.facebook.com/33listan
Winner of the 33 list competition in southern Sweden
2017-03-08 22:07
In tough competition Spectronic Medical came out on top in the 33-list* pitching competition held in Malmö on the 8th of March. Thereby Spectronic Medical has now earned a place one 33-list; enlisting the 33 hottest young technology companies in Sweden.
The Jury Motivation:
"Spectronic Medical uses powerful, self-learning algorithms with ingenious elimination of CT radiation to create a cancer treatment that is more precise, gentle, and without human error."
Read more on the links below (in Swedish):
Ny Teknik: http://www.nyteknik.se/startup/33-listan/spectronic-medical-vann-33-plats-i-malmo-6830981
Winning interview with Spectronic Medical's CEO Carl Siversson: https://www.facebook.com/nyteknik/videos/790705387746955/?hc_ref=PAGES_TIMELINE
Affärsvärlden: http://www.affarsvarlden.se/bors-ekonominyheter/spectronic-medical-vann-33-plats-i-malmo-6831016
*The 33-list, listing "Sweden's 33 hottest young technology companies", is compiled jointly by the editorial staff of the magazines Ny Teknik and Affärsvärlden. The complete list of all companies will be presented in Stockholm on the 4th of April at Münchenbryggeriet.
The Jury Motivation:
"Spectronic Medical uses powerful, self-learning algorithms with ingenious elimination of CT radiation to create a cancer treatment that is more precise, gentle, and without human error."
Read more on the links below (in Swedish):
Ny Teknik: http://www.nyteknik.se/startup/33-listan/spectronic-medical-vann-33-plats-i-malmo-6830981
Winning interview with Spectronic Medical's CEO Carl Siversson: https://www.facebook.com/nyteknik/videos/790705387746955/?hc_ref=PAGES_TIMELINE
Affärsvärlden: http://www.affarsvarlden.se/bors-ekonominyheter/spectronic-medical-vann-33-plats-i-malmo-6831016
*The 33-list, listing "Sweden's 33 hottest young technology companies", is compiled jointly by the editorial staff of the magazines Ny Teknik and Affärsvärlden. The complete list of all companies will be presented in Stockholm on the 4th of April at Münchenbryggeriet.
Spectronic Medical is selected to join the 33-list pitching competition
2017-03-01 12:41
Spectronic Medical is selected to join the 33-list pitching competition for a place on the 33-list. The 33-list, listing "Sweden's 33 hottest young technology companies", is compiled jointly by the editorial staff of the magazines Ny Teknik and Affärsvärlden. “It is very exciting to be selected to present our technology to a wider audience” said Dr. Carl Siversson, CEO of Spectronic Medical. “While there only is a very short time for presenting a complex technology we will gladly take on the challenge to spread awareness of the positive development going on within the cancer care area”.
Wish us good luck and join us, for free, at Media Evolution in Malmö on the 8th March. Sign up at: http://talentumevents.se/33listan/
Wish us good luck and join us, for free, at Media Evolution in Malmö on the 8th March. Sign up at: http://talentumevents.se/33listan/
Spectronic Medical joins part three of the gentle radiotherapy project
2017-02-03 10:02
The gentle radiotherapy research project aims to create a large-scale national cancer therapy platform, with fully integrated MRI only workflow in the participating clinics. The individual clinics are responsible for developing treatment procedures for a specific cancer diagnosis; e.g. prostate, rectum, head-neck and brain. Hence, the project as a whole aims to cover the major parts of the body where MR images are relevant for therapy. The role of Spectronic Medical in the project is to supply the technology for creation of synthetic CT’s (sCT) as well as technology for QA of geometric distortion.
“The steps taken by Gentle Radiotherapy project to advance MRI only treatment planning are very well aligned with our development efforts” says Dr. Carl Siversson, CEO of Spectronic Medical. “We are of course supporting the transition to MRI only based treatments and will strengthen our development efforts to be able to supply technology for more anatomical regions”.
Today Spectronic Medical have a CE Marked product for generation of sCT’s for prostate cancer radiotherapy.
“The steps taken by Gentle Radiotherapy project to advance MRI only treatment planning are very well aligned with our development efforts” says Dr. Carl Siversson, CEO of Spectronic Medical. “We are of course supporting the transition to MRI only based treatments and will strengthen our development efforts to be able to supply technology for more anatomical regions”.
Today Spectronic Medical have a CE Marked product for generation of sCT’s for prostate cancer radiotherapy.
Spectronic Medical receives CE Mark for MriPlanner
2016-06-16 16:36
Spectronic Medical announced today that it has received CE Mark approval for the commercial sale of its MriPlanner product. MriPlanner is the innovative product enabling MRI only based radiation therapy treatment planning for prostate cancer.
“This is a major milestone in radiation therapy. MriPlanner eliminates the troublesome usage of dual imaging modalities, reducing both complexity and cost while bringing increased treatment performance” said Dr. Carl Siversson, CEO of Spectronic Medical.
Today both Magnetic Resonance (MR) and Computed Tomography (CT) images are used in radiation therapy. An MR image is superior to a CT when it comes to contrast of soft tissue, enabling medical staff to improve treatment of the disease. However, the CT image has so far still been needed since the MR image lacks the electron density information required for radiation dose calculations. Unfortunately, usage of dual imaging modalities does not come without drawbacks. Matching the two images, taken in different scanners at different times, will always introduce uncertainties. Secondly, using two scanners is more expensive both with regard to equipment and manual labor. Finally, the dual scanner workflow requires careful scheduling of patients and also adds additional discomfort for the patients, who are already in a very exposed situation.
MriPlanner now addresses these problems by generating a synthetic CT (sCT) from a single MR image. In addition, suggested delineations of organs at risk (OAR) are also provided; greatly reducing the time required for clinical personnel to create the final treatment plan.
“Besides the obvious benefits of basing the radiotherapy treatment plan on a MR image this also paves the way for adaptive treatments, which has not been possible with the conventional CT based workflow” commented Carl Siversson.
“This is a major milestone in radiation therapy. MriPlanner eliminates the troublesome usage of dual imaging modalities, reducing both complexity and cost while bringing increased treatment performance” said Dr. Carl Siversson, CEO of Spectronic Medical.
Today both Magnetic Resonance (MR) and Computed Tomography (CT) images are used in radiation therapy. An MR image is superior to a CT when it comes to contrast of soft tissue, enabling medical staff to improve treatment of the disease. However, the CT image has so far still been needed since the MR image lacks the electron density information required for radiation dose calculations. Unfortunately, usage of dual imaging modalities does not come without drawbacks. Matching the two images, taken in different scanners at different times, will always introduce uncertainties. Secondly, using two scanners is more expensive both with regard to equipment and manual labor. Finally, the dual scanner workflow requires careful scheduling of patients and also adds additional discomfort for the patients, who are already in a very exposed situation.
MriPlanner now addresses these problems by generating a synthetic CT (sCT) from a single MR image. In addition, suggested delineations of organs at risk (OAR) are also provided; greatly reducing the time required for clinical personnel to create the final treatment plan.
“Besides the obvious benefits of basing the radiotherapy treatment plan on a MR image this also paves the way for adaptive treatments, which has not been possible with the conventional CT based workflow” commented Carl Siversson.
MR in RT 2016 participation and preliminary results from MR-OPERA study
2016-06-01 15:44
Spectronic Medical will participate at the MRinRT symposium held in Ann Arbor, Michigan (US) on the 18th – 19th June 2016.
In May, full enrollment of the 170-patient MR-OPERA Study was completed and some very promising initial results will be announced at the MRinRT symposium. The MR-OPERA Study aims to validate the MriPlanner software for MR to CT conversion for the use in a MR only prostate external radiotherapy workflow. Using a multi-center study setup, at the four principal university hospitals of Sweden, CT-based treatment plans are compared to synthetic CT plans for 170 prostate cancer patients.
In May, full enrollment of the 170-patient MR-OPERA Study was completed and some very promising initial results will be announced at the MRinRT symposium. The MR-OPERA Study aims to validate the MriPlanner software for MR to CT conversion for the use in a MR only prostate external radiotherapy workflow. Using a multi-center study setup, at the four principal university hospitals of Sweden, CT-based treatment plans are compared to synthetic CT plans for 170 prostate cancer patients.
Spectronic Medical presents the Statistical decomposition algorithm
2015-10-15 11:46
In a new scientific paper [Siversson et al, Med. Phys. 42, 6090 (2015)] Dr. Carl Siversson, CEO of Spectronic Medical, presents the patented Statistical decomposition algorithm (SDA). The SDA provides a method for automatic generation of synthetic CT (sCT) images from a single MR image volume. The algorithm is based on automatic tissue classification in combination with a model trained using a multimodal template material.
The presented study compares dose calculations between sCT generated by the SDA and conventional CT in the male pelvic region. The conclusion is that SDA enables a highly accurate MRI only workflow in prostate radiotherapy planning. The dosimetric uncertainties originating from the SDA appear negligible and are notably lower than the uncertainties introduced by variations in patient geometry between imaging sessions.
https://www.ncbi.nlm.nih.gov/pubmed/26429284
The presented study compares dose calculations between sCT generated by the SDA and conventional CT in the male pelvic region. The conclusion is that SDA enables a highly accurate MRI only workflow in prostate radiotherapy planning. The dosimetric uncertainties originating from the SDA appear negligible and are notably lower than the uncertainties introduced by variations in patient geometry between imaging sessions.
https://www.ncbi.nlm.nih.gov/pubmed/26429284